Trius Therapeutics Inc 4
4 · Trius Therapeutics Inc · Filed Jul 16, 2013
Insider Transaction Report
Form 4
Finn John
Chief Scientific Officer
Transactions
- Sale
Common Stock
2013-07-15$10.55/sh−3,500$36,925→ 167,860 total(indirect: By Trust)
Holdings
- 2,151
Common Stock
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2012